23.07.2013 Views

CMS Manual System - Louisiana Department of Health and Hospitals

CMS Manual System - Louisiana Department of Health and Hospitals

CMS Manual System - Louisiana Department of Health and Hospitals

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

criteria for evaluating the benefit(s) <strong>of</strong> the medication, <strong>and</strong> recognizing <strong>and</strong> evaluating<br />

adverse consequences. Monitoring parameters are based on the resident‘s condition, the<br />

pharmacologic properties <strong>of</strong> the medication being used <strong>and</strong> its associated risks,<br />

individualized therapeutic goals, <strong>and</strong> the potential for clinically significant adverse<br />

consequences.<br />

Adverse consequences related to medications are common enough to warrant serious<br />

attention <strong>and</strong> close monitoring. For example, a study reported that 338 (42%) <strong>of</strong> 815<br />

adverse drug events were judged preventable, <strong>and</strong> that common omissions included<br />

inadequate monitoring <strong>and</strong> either lack <strong>of</strong> response or a delayed response to signs,<br />

symptoms, or laboratory evidence <strong>of</strong> medication toxicity. 55<br />

Sources <strong>of</strong> information to facilitate defining the monitoring criteria or parameters may<br />

include cautions, warnings, <strong>and</strong> identified adverse consequences from:<br />

Manufacturers‘ package inserts <strong>and</strong> black-box warnings;<br />

Facility policies <strong>and</strong> procedures;<br />

Pharmacists;<br />

Clinical practice guidelines or clinical st<strong>and</strong>ards <strong>of</strong> practice;<br />

Medication references; <strong>and</strong><br />

Clinical studies or evidence-based review articles that are published in medical<br />

<strong>and</strong>/or pharmacy journals.<br />

Monitoring <strong>of</strong> the resident‘s response to any medication(s) is essential to evaluate the<br />

ongoing benefits as well as risks <strong>of</strong> various medications. It is important, for example, to<br />

monitor the effectiveness <strong>of</strong> medications used to address behavioral symptoms (e.g.,<br />

behavioral monitoring) or to treat hypertension (e.g., periodic pulse <strong>and</strong> blood pressure).<br />

Monitoring for adverse consequences involves ongoing vigilance <strong>and</strong> may periodically<br />

involve objective evaluation (e.g., assessing vital signs may be indicated if a medication<br />

is known to affect blood pressure, pulse rate <strong>and</strong> rhythm, or temperature). Using<br />

quantitative <strong>and</strong> qualitative monitoring parameters facilitates consistent <strong>and</strong> objective<br />

collection <strong>of</strong> information by the facility.<br />

Examples <strong>of</strong> tools that may be used by facility staff, practitioners, or consultants to<br />

determine baseline status as well as to monitor for effectiveness <strong>and</strong> potential adverse<br />

consequences may include, but are not limited to the following:<br />

Common<br />

Conditions/<br />

Symptoms<br />

Examples<br />

<strong>of</strong> Tools<br />

Potential<br />

Applications<br />

Source/Reference

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!